Health care providers and patients struggle to find critical medications as U.S. officials grapple with solutions.
Bringing drug manufacturing back home through incentives is key given critical vulnerabilities in U.S. drug supply and dependence on China.
Health care providers and patients struggle to find critical medications as U.S. officials grapple with solutions.
Bringing drug manufacturing back home through incentives is key given critical vulnerabilities in U.S. drug supply and dependence on China.